Close

Ratings by JPMorgan (Jessica Fye)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/11/2024 BeiGene, Ltd. BGNE Maintain Neutral
(N/A)
 
 
  Details
4/2/2024 Ascendis Pharma ASND Maintain Overweight
(N/A)
 
 
  Details
3/26/2024 Stoke Therapeutics STOK Maintain Neutral
(N/A)
 
 
  Details
3/25/2024 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
3/22/2024 BioNTech BNTX Maintain Underweight
(N/A)
 
 
  Details
3/20/2024 BioNTech BNTX Maintain Neutral
(N/A)
 
 
  Details
3/20/2024 Immunocore Holdings IMCR Maintain Overweight
(N/A)
 
 
  Details
3/20/2024 Deciphera DCPH Maintain Neutral
(N/A)
 
 
  Details
3/19/2024 NovoCure Ltd. NVCR Maintain Neutral
(N/A)
 
 
  Details
3/19/2024 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
3/13/2024 Legend Biotech Corp. LEGN Maintain Overweight
(N/A)
 
 
  Details
3/13/2024 Crinetics CRNX Maintain Overweight
(N/A)
 
 
  Details
3/4/2024 United Therapeutics Corp. UTHR Maintain Overweight
(N/A)
 
 
  Details
2/29/2024 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
2/7/2024 Ascendis Pharma ASND Maintain Overweight
(N/A)
 
 
  Details
2/6/2024 Vertex VRTX Maintain Overweight
(N/A)
 
 
  Details
2/6/2024 BeiGene, Ltd. BGNE New Coverage Overweight
(N/A)
141.81
(134.05)
-5.47% Details
2/1/2024 Vertex VRTX Maintain Overweight
(N/A)
 
 
  Details
2/1/2024 Ionis Pharmaceuticals IONS Maintain Neutral
(N/A)
 
 
  Details
1/5/2024 Ascendis Pharma ASND Maintain Overweight
(N/A)
 
 
  Details
1/4/2024 Incyte INCY Maintain Neutral
(N/A)
 
 
  Details
12/28/2023 RayzeBio RYZB Downgrade Neutral
(Overweight)
61.40
(62.49)
1.78% Details
12/28/2023 Cerevel Therapeutics CERE Maintain Neutral
(N/A)
 
 
  Details
12/28/2023 Karuna Therapeutics Inc. KRTX Downgrade Neutral
(Overweight)
317.00
(329.83)
4.05% Details
12/1/2023 Moderna MRNA Maintain Underweight
(N/A)
 
 
  Details
12/1/2023 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
12/1/2023 BioNTech BNTX Downgrade Underweight
(Neutral)
99.25
(86.34)
-13.01% Details
11/20/2023 Nektar Therapeutics NKTR New Coverage Underweight
(N/A)
0.50
(1.49)
198% Details
11/20/2023 Emergent BioSolutions EBS New Coverage Underweight
(N/A)
2.12
(1.95)
-8.02% Details
11/20/2023 Esperion Therapeutics ESPR New Coverage Neutral
(N/A)
1.11
(1.91)
72.07% Details
11/20/2023 Stoke Therapeutics STOK New Coverage Neutral
(N/A)
4.17
(12.45)
198.56% Details
11/20/2023 Amarin Corporation AMRN New Coverage Underweight
(N/A)
0.76
(0.90)
18.42% Details
11/20/2023 Deciphera DCPH New Coverage Neutral
(N/A)
12.25
(14.84)
21.14% Details
11/20/2023 BioCryst Pharma BCRX New Coverage Overweight
(N/A)
5.14
(4.61)
-10.31% Details
11/20/2023 NovoCure Ltd. NVCR New Coverage Neutral
(N/A)
11.83
(12.46)
5.33% Details
11/20/2023 Mirum Pharamceuticals MIRM New Coverage Overweight
(N/A)
30.31
(24.01)
-20.79% Details
11/20/2023 Crinetics CRNX New Coverage Overweight
(N/A)
28.34
(43.49)
53.46% Details
11/20/2023 Immunocore Holdings IMCR New Coverage Overweight
(N/A)
46.89
(53.37)
13.82% Details
11/20/2023 Denali Therapeutics Inc. DNLI New Coverage Overweight
(N/A)
18.13
(17.34)
-4.36% Details
11/20/2023 Insmed INSM New Coverage Overweight
(N/A)
24.44
(26.15)
7% Details
11/20/2023 Alkermes ALKS New Coverage Neutral
(N/A)
23.37
(23.77)
1.71% Details
11/20/2023 Cerevel Therapeutics CERE New Coverage Neutral
(N/A)
24.65
(41.31)
67.59% Details
11/2/2023 United Therapeutics Corp. UTHR Maintain Overweight
(N/A)
 
 
  Details
10/10/2023 RayzeBio RYZB New Coverage Overweight
(N/A)
20.59
(62.49)
203.5% Details
6/5/2023 Karuna Therapeutics Inc. KRTX Maintain Overweight
(N/A)
 
 
  Details
6/5/2023 Intra-Cellular Therapies ITCI Maintain Overweight
(N/A)
 
 
  Details
5/25/2023 Alkermes ALKS Maintain Neutral
(N/A)
 
 
  Details
5/4/2023 United Therapeutics Corp. UTHR Maintain Overweight
(N/A)
 
 
  Details
5/3/2023 Incyte INCY Maintain Neutral
(N/A)
 
 
  Details
5/2/2023 Vertex VRTX Maintain Overweight
(N/A)
 
 
  Details
4/28/2023 Ascendis Pharma ASND Maintain Overweight
(N/A)
 
 
  Details
4/27/2023 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
4/25/2023 Alkermes ALKS Maintain Neutral
(N/A)
 
 
  Details
4/21/2023 Stoke Therapeutics STOK Maintain Overweight
(N/A)
 
 
  Details
4/21/2023 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
4/21/2023 Crinetics CRNX Maintain Overweight
(N/A)
 
 
  Details
4/19/2023 Legend Biotech Corp. LEGN Maintain Overweight
(N/A)
 
 
  Details
4/12/2023 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
4/10/2023 BioNTech BNTX Maintain Neutral
(N/A)
 
 
  Details
4/10/2023 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
3/17/2023 Emergent BioSolutions EBS Downgrade Underweight
(Neutral)
9.65
(1.95)
-79.79% Details
3/17/2023 Cerevel Therapeutics CERE Downgrade Neutral
(Overweight)
24.32
(41.31)
69.86% Details
3/17/2023 NovoCure Ltd. NVCR Downgrade Underweight
(Neutral)
64.43
(12.46)
-80.66% Details
3/9/2023 Intra-Cellular Therapies ITCI Maintain Overweight
(N/A)
 
 
  Details
3/7/2023 Cara Therapeutics CARA Maintain Overweight
(N/A)
 
 
  Details
2/28/2023 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
2/27/2023 Esperion Therapeutics ESPR Maintain Neutral
(N/A)
 
 
  Details
2/24/2023 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
2/23/2023 United Therapeutics Corp. UTHR Maintain Overweight
(N/A)
 
 
  Details
2/22/2023 Halozyme Therapeutics HALO Maintain Overweight
(N/A)
 
 
  Details
2/22/2023 BioCryst Pharma BCRX Maintain Overweight
(N/A)
 
 
  Details
2/17/2023 Ascendis Pharma ASND Maintain Overweight
(N/A)
 
 
  Details
2/16/2023 Seagen SGEN Maintain Overweight
(N/A)
 
 
  Details
2/13/2023 Seagen SGEN Maintain Overweight
(N/A)
 
 
  Details
2/8/2023 BioNTech BNTX Maintain Neutral
(N/A)
 
 
  Details
2/8/2023 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
2/7/2023 Incyte INCY Maintain Neutral
(N/A)
 
 
  Details
1/6/2023 NovoCure Ltd. NVCR Maintain Neutral
(N/A)
 
 
  Details
1/3/2023 Stoke Therapeutics STOK Maintain Overweight
(N/A)
 
 
  Details
1/3/2023 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
12/22/2022 NovoCure Ltd. NVCR Maintain Neutral
(N/A)
 
 
  Details
12/6/2022 Alkermes ALKS Maintain Neutral
(N/A)
 
 
  Details
11/22/2022 Immunocore Holdings IMCR Maintain Overweight
(N/A)
 
 
  Details
11/22/2022 Halozyme Therapeutics HALO Maintain Overweight
(N/A)
 
 
  Details
11/21/2022 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
11/21/2022 BioNTech BNTX Maintain Neutral
(N/A)
 
 
  Details
11/11/2022 Emergent BioSolutions EBS Maintain Neutral
(N/A)
 
 
  Details
11/10/2022 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
11/8/2022 Cara Therapeutics CARA Maintain Overweight
(N/A)
 
 
  Details
11/7/2022 Karuna Therapeutics Inc. KRTX Maintain Overweight
(N/A)
 
 
  Details
11/4/2022 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
11/4/2022 Intra-Cellular Therapies ITCI Maintain Overweight
(N/A)
 
 
  Details
11/3/2022 United Therapeutics Corp. UTHR Maintain Overweight
(N/A)
 
 
  Details
11/2/2022 Esperion Therapeutics ESPR Maintain Neutral
(N/A)
 
 
  Details
10/31/2022 Seagen SGEN Maintain Overweight
(N/A)
 
 
  Details
10/27/2022 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
10/26/2022 Esperion Therapeutics ESPR Maintain Neutral
(N/A)
 
 
  Details
10/26/2022 Emergent BioSolutions EBS Maintain Neutral
(N/A)
 
 
  Details
10/25/2022 Tricida TCDA Downgrade Underweight
(Neutral)
10.88
(0.11)
-98.99% Details
10/24/2022 Seagen SGEN Maintain Overweight
(N/A)
 
 
  Details
10/24/2022 Moderna MRNA Maintain Neutral
(N/A)
 
 
  Details
10/24/2022 Incyte INCY Maintain Neutral
(N/A)
 
 
  Details
10/24/2022 BioNTech BNTX Maintain Neutral
(N/A)
 
 
  Details
10/24/2022 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
10/24/2022 Vertex VRTX Maintain Overweight
(N/A)
 
 
  Details
10/24/2022 Ionis Pharmaceuticals IONS Maintain Neutral
(N/A)
 
 
  Details
10/21/2022 United Therapeutics Corp. UTHR Maintain Overweight
(N/A)
 
 
  Details
10/21/2022 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
8/8/2022 Nektar Therapeutics NKTR Downgrade Underweight
(Neutral)
4.42
(1.49)
-66.29% Details
8/2/2022 Vertex VRTX New Coverage Overweight
(N/A)
280.41
(394.17)
40.57% Details
8/2/2022 Seagen SGEN New Coverage Overweight
(N/A)
179.98
(228.74)
27.09% Details
8/2/2022 NovoCure Ltd. NVCR New Coverage Neutral
(N/A)
67.99
(12.46)
-81.67% Details
8/2/2022 Moderna MRNA New Coverage Neutral
(N/A)
164.09
(103.79)
-36.75% Details
8/2/2022 Legand Biotech Corp. LEGN New Coverage Overweight
(N/A)
47.24
(50.12)
6.1% Details
8/2/2022 Karuna Therapeutics Inc. KRTX New Coverage Overweight
(N/A)
130.25
(329.83)
153.23% Details
8/2/2022 Incyte INCY New Coverage Neutral
(N/A)
77.68
(53.22)
-31.49% Details
8/2/2022 Cerevel Therapeutics CERE New Coverage Overweight
(N/A)
26.29
(41.31)
57.13% Details
8/2/2022 BioNTech BNTX New Coverage Neutral
(N/A)
165.15
(86.34)
-47.72% Details
8/2/2022 BioMarin Pharmaceutical Inc. BMRN New Coverage Overweight
(N/A)
86.05
(90.87)
5.6% Details
8/2/2022 Alkermes ALKS New Coverage Neutral
(N/A)
25.60
(23.77)
-7.15% Details
6/7/2022 Zymeworks ZYME Maintain Neutral
(N/A)
 
 
  Details
6/6/2022 Amarin Corporation AMRN Maintain Underweight
(N/A)
 
 
  Details
5/24/2022 United Therapeutics Corp. UTHR Maintain Overweight
(N/A)
 
 
  Details
5/19/2022 Radius Health RDUS Maintain Neutral
(N/A)
 
 
  Details
5/6/2022 Amarin Corporation AMRN Downgrade Underweight
(Neutral)
1.56
(0.90)
-42.31% Details
5/5/2022 Esperion Therapeutics ESPR Upgrade Neutral
(Underweight)
6.53
(1.91)
-70.75% Details
5/2/2022 Halozyme Therapeutics HALO Maintain Overweight
(N/A)
 
 
  Details
4/20/2022 Lava Therapeutics NV LVTX Maintain Overweight
(N/A)
 
 
  Details
4/19/2022 United Therapeutics Corp. UTHR Maintain Overweight
(N/A)
 
 
  Details
4/13/2022 Zymeworks ZYME Maintain Neutral
(N/A)
 
 
  Details
3/25/2022 Radius Health RDUS Maintain Neutral
(N/A)
 
 
  Details
3/24/2022 Ionis Pharmaceuticals IONS Maintain Neutral
(N/A)
 
 
  Details
3/14/2022 Cara Therapeutics CARA Maintain Overweight
(N/A)
 
 
  Details
3/9/2022 Emergent BioSolutions EBS Maintain Neutral
(N/A)
 
 
  Details
3/8/2022 Cara Therapeutics CARA Upgrade Overweight
(Neutral)
10.70
(0.71)
-93.36% Details
3/1/2022 Nektar Therapeutics NKTR Maintain Neutral
(N/A)
 
 
  Details
2/28/2022 Rubius RUBY Maintain Neutral
(N/A)
 
 
  Details
2/25/2022 United Therapeutics Corp. UTHR Maintain Overweight
(N/A)
 
 
  Details
2/25/2022 BioCryst Pharma BCRX Maintain Overweight
(N/A)
 
 
  Details
2/7/2022 Radius Health RDUS Maintain Neutral
(N/A)
 
 
  Details
2/7/2022 Amarin Corporation AMRN Maintain Neutral
(N/A)
 
 
  Details
2/7/2022 Intra-Cellular Therapies ITCI Maintain Overweight
(N/A)
 
 
  Details
1/3/2022 Landos Biopharma LABP Maintain Neutral
(N/A)
 
 
  Details
11/22/2021 Stoke Therapeutics STOK Upgrade Overweight
(Neutral)
28.06
(12.45)
-55.63% Details
11/16/2021 Tricida TCDA Upgrade Neutral
(Underweight)
5.46
(0.11)
-97.99% Details
11/12/2021 Crinetics CRNX Maintain Overweight
(N/A)
 
 
  Details
9/20/2021 Mirum Pharamceuticals MIRM New Coverage Overweight
(N/A)
18.33
(24.01)
30.99% Details
9/15/2021 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
8/20/2021 Aprea APRE Downgrade Underweight
(Neutral)
3.62
(5.85)
61.6% Details
8/3/2021 Cara Therapeutics CARA New Coverage Neutral
(N/A)
11.97
(0.71)
-94.07% Details
8/3/2021 Magenta Therapeutics MGTA Downgrade Neutral
(Overweight)
7.12
(0.70)
-90.17% Details
7/28/2021 Intra-Cellular Therapies ITCI Maintain Overweight
(N/A)
 
 
  Details
6/23/2021 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
6/18/2021 Crinetics CRNX Upgrade Overweight
(Overweight)
18.50
(43.49)
135.08% Details
6/16/2021 Kaleido Biosciences Inc. KLDO Maintain Underweight
(N/A)
 
 
  Details
5/21/2021 Stoke Therapeutics STOK Maintain
(N/A)
 
 
  Details
5/21/2021 Mersana MRSN Maintain Neutral
(N/A)
 
 
  Details
5/21/2021 Crinetics CRNX Maintain Neutral
(N/A)
 
 
  Details
5/19/2021 Jazz Pharmaceuticals JAZZ New Coverage Overweight
(N/A)
175.09
(108.90)
-37.8% Details
4/19/2021 Lava Therapeutics NV LVTX New Coverage Overweight
(N/A)
15.62
(2.89)
-81.5% Details
3/2/2021 Immunocore Holdings IMCR New Coverage Overweight
(N/A)
48.36
(53.37)
10.36% Details
3/1/2021 Landos Biopharma LABP New Coverage Neutral
(N/A)
12.99
(21.52)
65.67% Details
1/29/2021 Aptinyx APTX Downgrade Underweight
(Neutral)
3.70
(0.06)
-98.38% Details
1/29/2021 Lexicon Pharmaceuticals LXRX Upgrade Neutral
(Underweight)
8.06
(1.70)
-78.91% Details
10/14/2020 Magenta Therapeutics MGTA New Coverage Overweight
(N/A)
7.67
(0.70)
-90.87% Details
10/14/2020 Crinetics CRNX New Coverage Neutral
(N/A)
16.77
(18.50)
10.32% Details
9/29/2020 Tricida TCDA New Coverage Underweight
(N/A)
8.87
(0.11)
-98.76% Details
9/29/2020 Aprea APRE New Coverage Neutral
(N/A)
22.65
(5.85)
-74.17% Details
9/29/2020 Radius Health RDUS New Coverage Neutral
(N/A)
10.80
(17.43)
61.39% Details
9/29/2020 BioCryst Pharma BCRX New Coverage Overweight
(N/A)
3.67
(4.61)
25.61% Details
9/29/2020 Immunogen Inc. IMGN New Coverage Neutral
(N/A)
3.58
(31.25)
772.91% Details
9/29/2020 Esperion Therapeutics ESPR New Coverage Underweight
(N/A)
37.12
(1.91)
-94.85% Details
9/29/2020 Stoke Therapeutics STOK New Coverage Neutral
(N/A)
34.93
(12.45)
-64.36% Details
9/29/2020 Mersana MRSN New Coverage Neutral
(N/A)
19.60
(3.76)
-80.82% Details
9/29/2020 Zymeworks ZYME New Coverage Neutral
(N/A)
44.98
(8.93)
-80.15% Details
9/14/2020 Deciphera DCPH New Coverage Neutral
(N/A)
44.87
(14.84)
-66.93% Details
9/14/2020 Nektar Therapeutics NKTR New Coverage Neutral
(N/A)
18.82
(1.49)
-92.08% Details
9/14/2020 Denali Therapeutics Inc. DNLI New Coverage Overweight
(N/A)
31.99
(17.34)
-45.8% Details
9/14/2020 Arena Pharma ARNA New Coverage Overweight
(N/A)
63.37
(99.98)
57.77% Details
9/14/2020 Halozyme Therapeutics HALO New Coverage Overweight
(N/A)
27.05
(38.38)
41.89% Details
9/14/2020 United Therapeutics Corp. UTHR New Coverage Overweight
(N/A)
102.52
(231.78)
126.08% Details
9/14/2020 Emergent BioSolutions EBS New Coverage Neutral
(N/A)
98.08
(1.95)
-98.01% Details
9/14/2020 Ionis Pharmaceuticals IONS New Coverage Neutral
(N/A)
51.97
(41.54)
-20.07% Details
9/14/2020 Ascendis Pharma ASND New Coverage Overweight
(N/A)
144.70
(141.50)
-2.21% Details
9/14/2020 Jazz Pharmaceuticals JAZZ New Coverage Overweight
(N/A)
136.80
(175.09)
27.99% Details
4/6/2020 Yum! Brands YUM Maintain Neutral
(N/A)
 
 
  Details
1/31/2020 United Therapeutics Corp. UTHR Upgrade Overweight
(Neutral)
96.42
(231.78)
140.39% Details
1/31/2020 Rubius RUBY Downgrade Neutral
(Overweight)
8.05
(0.08)
-99.01% Details
1/31/2020 Intra-Cellular Therapies ITCI Downgrade Neutral
(Overweight)
23.54
(79.84)
239.17% Details
1/31/2020 Arena Pharma ARNA Upgrade Overweight
(Neutral)
44.44
(99.98)
124.98% Details
1/6/2020 Amarin Corporation AMRN New Coverage Neutral
(N/A)
21.53
(0.90)
-95.82% Details
12/9/2019 Zymeworks ZYME New Coverage Neutral
(N/A)
41.92
(8.93)
-78.7% Details
10/28/2019 Aprea APRE New Coverage Neutral
(N/A)
25.70
(5.85)
-77.24% Details
8/13/2019 Aptinyx APTX Downgrade Underweight
(Neutral)
3.53
(0.06)
-98.3% Details
8/9/2019 Nektar Therapeutics NKTR Downgrade Neutral
(Overweight)
29.57
(1.49)
-94.96% Details
3/25/2019 Kaleido Biosciences Inc. KLDO New Coverage Neutral
(N/A)
13.52
(0.29)
-97.86% Details
3/19/2019 Yum! Brands YUM Downgrade Neutral
(Overweight)
100.90
(138.00)
36.77% Details
3/19/2019 Immunogen Inc. IMGN Downgrade Underweight
(Neutral)
2.65
(31.25)
1079.25% Details
3/13/2019 Esperion Therapeutics ESPR Upgrade Neutral
(Underweight)
49.81
(1.91)
-96.17% Details
3/11/2019 Mersana MRSN Downgrade Underweight
(Neutral)
4.22
(3.76)
-10.9% Details
1/17/2019 Aptinyx APTX Downgrade Neutral
(Overweight)
17.83
(3.53)
-80.2% Details
12/11/2018 Stemline Therapeutics STML New Coverage Overweight
(N/A)
9.98
(11.83)
18.54% Details
11/6/2018 AMAG Pharmaceuticals AMAG Downgrade Underweight
(Neutral)
18.29
(13.75)
-24.82% Details
8/13/2018 Crinetics CRNX New Coverage Neutral
(N/A)
29.84
(43.49)
45.74% Details
8/13/2018 Rubius RUBY New Coverage Overweight
(N/A)
21.93
(0.08)
-99.64% Details